Show Summary Details
Page of

Chronic kidney disease-mineral and bone disorder (CKD-MBD) in children 

Chronic kidney disease-mineral and bone disorder (CKD-MBD) in children
Chapter:
Chronic kidney disease-mineral and bone disorder (CKD-MBD) in children
Author(s):

Sevcan A. Bakkaloglu

, Katherine Wesseling-Perry

, and Isidro B. Salusky

DOI:
10.1093/med/9780199559176.003.028
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2020. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 23 February 2020

Abnormalities in mineral metabolism and bone structure are an almost universal finding in chronic kidney disease (CKD) in childhood,1 and result in significant complications. Many are similar to those as well as the alterations in bone turnover, mineralization and volume common to the adult population.

Accordingly, treatment and prevention of renal bone diseases is of critical importance in managing the alterations in bone and growth plate that occur early in the course of CKD and are accompanied by the development of cardiovascular complications. A growing body of evidence demonstrates that cardiovascular disease is the leading cause of morbidity and mortality in adult and pediatric patients with CKD, and that therapies designed to treat the skeletal consequences of CKD affect the progression of vascular pathology. Such findings led to a reclassification of the biochemical, skeletal, and vascular complications associated with progressive kidney disease. Together, these alterations are termed ‘CKD mineral and bone disorder’ (‘CKD-MBD’), while the term ‘renal osteodystrophy’ exclusively defines bone morphology and is therefore one aspect of the CKD-MBD. This chapter summarizes the specific aspects related to normal skeletal development, and the major aspects of the pathogenesis, clinical manifestations, histological features, and therapeutic interventions currently used in the management of CKD-MBD. Particular emphasis has been placed on the clinical manifestations and treatment strategies that distinguish pediatric patients from their adult counterparts, and on the differences in the management of CKD-MBD across the spectrum of CKD.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.